Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.0000+0.0900 (+1.83%)
At close: 04:00PM EDT
5.0200 +0.02 (+0.40%)
After hours: 06:58PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts8897
Avg. Estimate-0.13-0.14-0.51-0.61
Low estimate-0.2-0.21-0.65-0.91
High estimate-0.1-0.1-0.41-0.41
Year ago EPS0.08-0.10.5-0.51
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts7797
Avg. Estimate11.71M12.02M45.07M65.52M
Low estimate9M9M39M48M
High estimate14M16.23M52.4M76.4M
Year ago sales74.95M21.55M485.42M45.07M
Sales growth (year/est)-84.40%-44.20%-90.70%45.40%
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS0.040-0.14-0.13
Actual EPS0.08-0.1-0.14-0.11
Difference0.04-0.100.02
Surprise %100.00%N/A0.00%15.40%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate-0.13-0.14-0.51-0.61
7 days ago-0.13-0.14-0.51-0.61
30 days ago-0.13-0.13-0.49-0.56
60 days ago-0.14-0.15-0.54-0.6
90 days ago-0.14-0.15-0.54-0.6
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1221
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.-262.50%N/AN/AN/A
Next qtr.-40.00%N/AN/AN/A
Current year-202.00%N/AN/AN/A
Next year-19.60%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A